BRPI1014362A2 - método e composição para sincronizar o tempo de inseminação - Google Patents

método e composição para sincronizar o tempo de inseminação

Info

Publication number
BRPI1014362A2
BRPI1014362A2 BRPI1014362A BRPI1014362A BRPI1014362A2 BR PI1014362 A2 BRPI1014362 A2 BR PI1014362A2 BR PI1014362 A BRPI1014362 A BR PI1014362A BR PI1014362 A BRPI1014362 A BR PI1014362A BR PI1014362 A2 BRPI1014362 A2 BR PI1014362A2
Authority
BR
Brazil
Prior art keywords
synchronize
composition
insemination time
insemination
time
Prior art date
Application number
BRPI1014362A
Other languages
English (en)
Inventor
Mark E Swanson
Stephen Kent Webel
Original Assignee
Pennatek Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennatek Llc filed Critical Pennatek Llc
Priority to BR122013009981-6A priority Critical patent/BR122013009981B1/pt
Publication of BRPI1014362A2 publication Critical patent/BRPI1014362A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00—Instruments or methods for reproduction or fertilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00—Instruments or methods for reproduction or fertilisation
    • A61D19/02—Instruments or methods for reproduction or fertilisation for artificial insemination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1014362A 2009-04-23 2010-04-23 método e composição para sincronizar o tempo de inseminação BRPI1014362A2 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122013009981-6A BR122013009981B1 (pt) 2009-04-23 2010-04-23 Composição para sincronizar o tempo de inseminação

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17200909P 2009-04-23 2009-04-23
PCT/US2010/032258 WO2010124220A1 (en) 2009-04-23 2010-04-23 Method and composition for synchronizing time of insemination

Publications (1)

Publication Number Publication Date
BRPI1014362A2 true BRPI1014362A2 (pt) 2016-04-05

Family

ID=43011504

Family Applications (2)

Application Number Title Priority Date Filing Date
BR122013009981-6A BR122013009981B1 (pt) 2009-04-23 2010-04-23 Composição para sincronizar o tempo de inseminação
BRPI1014362A BRPI1014362A2 (pt) 2009-04-23 2010-04-23 método e composição para sincronizar o tempo de inseminação

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR122013009981-6A BR122013009981B1 (pt) 2009-04-23 2010-04-23 Composição para sincronizar o tempo de inseminação

Country Status (11)

Country Link
US (5) US8905913B2 (pt)
EP (1) EP2421545B1 (pt)
CN (2) CN104906556B (pt)
BR (2) BR122013009981B1 (pt)
CA (1) CA2758532C (pt)
DK (1) DK2421545T3 (pt)
ES (1) ES2661240T3 (pt)
HU (1) HUE036576T2 (pt)
PL (1) PL2421545T3 (pt)
RU (1) RU2568839C2 (pt)
WO (1) WO2010124220A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540838C (en) 2003-10-03 2014-12-16 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
ES2661240T3 (es) 2009-04-23 2018-03-28 Jbs United Animal Health Ii Llc Método y composición para sincronizar el momento de inseminación
US9888990B2 (en) 2012-06-06 2018-02-13 Inguran, Llc Methods for use of sex sorted semen to improve genetic management in swine
MX357275B (es) 2012-06-06 2018-07-03 Mofa Group Llc Envase multi-compartimento para líquidos biológicos.
US9433195B2 (en) 2012-06-06 2016-09-06 Inguran, Llc Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells
WO2014085674A1 (en) * 2012-11-28 2014-06-05 Jbs United Animal Health Ii Llc Method for synchronizing time of insemination in gilts
WO2015081157A1 (en) * 2013-11-27 2015-06-04 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination in gilts
TW201625218A (zh) * 2014-04-18 2016-07-16 Jbs聯合動物保健有限責任公司 製造含gnrh凝膠之方法
CN105409871A (zh) * 2015-11-04 2016-03-23 宁波市三生药业有限公司 后备和经产母猪高效查情及同步受孕方法
CN105815273B (zh) * 2016-03-24 2018-10-09 赤峰家育种猪生态科技集团有限公司 一种恒定生产与目测管理相结合的种猪繁育方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
US12661321B2 (en) 2017-06-30 2026-06-23 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
WO2019118574A1 (en) * 2017-12-13 2019-06-20 Texas Tech University System Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use
CN110495967A (zh) * 2019-08-21 2019-11-26 吉林农业大学 一种同期排卵定时输精的方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860701A (en) 1968-04-22 1975-01-14 Searle & Co Method for use and compositions of 11-lower alkyl steroids and drug delivery system for the controlled elution of 11-lower alkyl steroids
CS180644B2 (en) 1973-09-29 1978-01-31 Takeda Chemical Industries Ltd Process for preparing nonapeptides
US4005063A (en) 1973-10-11 1977-01-25 Abbott Laboratories [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
US3991750A (en) 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SU573159A1 (ru) * 1976-03-17 1977-09-25 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Животноводства Способ синхронизации охоты и овул ции у свиноматок
US4756907A (en) 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4732763A (en) 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
JPS5781447A (en) 1980-11-11 1982-05-21 Toyo Jozo Co Ltd Human chorionic gonadotropic hormone c-terminal fragment
GB8428201D0 (en) 1984-11-08 1984-12-19 Glaxo Group Ltd Biological preparations
US4931279A (en) 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US4804626A (en) 1986-10-22 1989-02-14 The General Hospital Corporation Immunometric assay for the detection of human chorionic gonadotropin
US4780451B1 (en) 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
DE68907066T2 (de) 1988-01-29 1993-12-16 Koken Kk Verbesserte Formulierungen mit kontrollierter Abgabe.
US4975280A (en) 1989-01-23 1990-12-04 Ethyl Corporation Bioerodable sustained release implants
FR2663223B1 (fr) 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
US5180711A (en) 1990-06-14 1993-01-19 Applied Research Systems Ars Holding N.V. Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals
US5434136A (en) 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
HU222501B1 (hu) 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5444167A (en) 1993-07-07 1995-08-22 Wallac Oy Variant luteinizing hormone encoding DNA
NZ274711A (en) 1993-09-29 1996-11-26 Alza Corp Composition for administration of active agent by application to a body surface or membrane comprising permeability enhancing amount of monoglyceride(s) and lactate ester(s)
US5650173A (en) 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
FR2717688B1 (fr) 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5589457A (en) 1995-07-03 1996-12-31 Ausa International, Inc. Process for the synchronization of ovulation
GB9514816D0 (en) 1995-07-19 1995-09-20 Ucli Ltd Substances and their medical use
US5985320A (en) 1996-03-04 1999-11-16 The Penn State Research Foundation Materials and methods for enhancing cellular internalization
US6387390B1 (en) 1998-10-05 2002-05-14 The Penn State Research Foundation Compositions and methods for enhancing receptor-mediated cellular internalization
FR2747042B1 (fr) 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
AU2827797A (en) 1996-05-30 1998-01-05 Sepracor, Inc. Nsaids for regulating the reproductive cycle of domesticated animals
US6051558A (en) 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US6028057A (en) 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
FR2776520B1 (fr) 1998-03-25 2000-05-05 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
WO2000009113A1 (en) 1998-08-17 2000-02-24 Trout William E Use of zeranol to modulate reproductive cycles
AU5025300A (en) 1999-06-18 2001-01-09 Southern Biosystems, Inc. Compositions for controlled release of the hormone gnrh and its analogs
DE10050831A1 (de) * 2000-10-05 2002-05-02 Veyx Pharma Gmbh Verfahren zum Zyklusstart bei weiblichen Zuchttieren
GB0117057D0 (en) 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
DE602004030546D1 (de) 2003-03-04 2011-01-27 Aspenbio Pharma Inc LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers.
US7456207B2 (en) 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
CA2540838C (en) 2003-10-03 2014-12-16 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
AU2004285481A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
SG180041A1 (en) 2005-10-24 2012-05-30 Manawatu Biotech Invest Ltd Ovulation cycle monitoring and management
NZ595633A (en) 2005-12-02 2013-05-31 Parnell Lab Aust Pty Ltd Increasing pregnancy rates
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
EP1891941A1 (en) 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Aqueous gels comprising microspheres
EP2065032A1 (en) 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
ES2661240T3 (es) 2009-04-23 2018-03-28 Jbs United Animal Health Ii Llc Método y composición para sincronizar el momento de inseminación
JP2015506978A (ja) 2012-02-08 2015-03-05 ダウ コーニング コーポレーションDow Corning Corporation ヘルスケア有効成分の送達用シリコーンエマルション
WO2014085674A1 (en) 2012-11-28 2014-06-05 Jbs United Animal Health Ii Llc Method for synchronizing time of insemination in gilts
WO2015081157A1 (en) 2013-11-27 2015-06-04 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination in gilts
TW201625218A (zh) 2014-04-18 2016-07-16 Jbs聯合動物保健有限責任公司 製造含gnrh凝膠之方法

Also Published As

Publication number Publication date
US20160263180A1 (en) 2016-09-15
CN102596215A (zh) 2012-07-18
US20180133284A1 (en) 2018-05-17
US9757425B2 (en) 2017-09-12
BR122013009981A2 (pt) 2016-05-17
HUE036576T2 (hu) 2018-07-30
US8905913B2 (en) 2014-12-09
DK2421545T3 (en) 2018-03-12
WO2010124220A1 (en) 2010-10-28
CA2758532A1 (en) 2010-10-28
BR122013009981B1 (pt) 2020-02-11
CN102596215B (zh) 2015-04-29
US9352011B2 (en) 2016-05-31
ES2661240T3 (es) 2018-03-28
CN104906556A (zh) 2015-09-16
US10668127B2 (en) 2020-06-02
PL2421545T3 (pl) 2018-05-30
EP2421545A1 (en) 2012-02-29
CN104906556B (zh) 2025-04-25
US20200345806A1 (en) 2020-11-05
EP2421545A4 (en) 2013-05-15
US20150057225A1 (en) 2015-02-26
RU2568839C2 (ru) 2015-11-20
RU2011147472A (ru) 2013-05-27
HK1173373A1 (en) 2013-05-16
CA2758532C (en) 2017-07-25
US20120046519A1 (en) 2012-02-23
EP2421545B1 (en) 2017-12-06

Similar Documents

Publication Publication Date Title
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
BRPI0817547A2 (pt) Método para realizar pirólise
BRPI0914493A2 (pt) transportador e método para girar um artigo
BRPI1012525A2 (pt) composições de nanopatículas isentas de príons e métodos para sua fabricação
BRPI0911521A2 (pt) método e aparelho para fixação de um item móvel a uma estrutura
BRPI0921726A2 (pt) método e dispositivo para ativar células tronco
BRPI1013829A2 (pt) composições e métodos para fermentação de biomassa
BR112012032172A2 (pt) método para produzir um álcool e composição
BRPI1013145A2 (pt) metodos e aparelho para facilitar adaptacao sem sessao controlada pelo cliente
BRPI0921953A2 (pt) método e aparelho para sincronização de tempo
BRPI0906795A2 (pt) Método para produzir um l-aminoácido
BRPI0918299A2 (pt) Método para produzir um l-aminoácido
BR112012028540A2 (pt) composições e métodos para melhorar desempenho fisiológico e tempo de recuperação
BRPI0915460A2 (pt) métodos e composições para a liberação intensificada de macromoléculas
ES2397671T8 (es) Procedimiento para preparar voriconazol
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
BRPI0923833A2 (pt) Métodos para produzir um éster e amidas
BRPI0819050A2 (pt) Método para desidroaromatizar metano
BRPI0912755A2 (pt) Método para produzir um l-aminoácido
BRPI0913136A2 (pt) método para produzir uma peça e peça.
CR10905A (es) Proceso para producir biomasa y proteinas por microalgas
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI0910371A2 (pt) método para confeccionar uma estrutura laminada e estrutura laminada
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI0924019A2 (pt) método de fermentação e aparelhos adaptados para o método

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: JBS UNITED ANIMAL HEALTH II LLC (US)

B25D Requested change of name of applicant approved

Owner name: UNITED-AH II, LLC (US)